Susquehanna International Group, LLP Icosavax, Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$5.95 - $15.79 $83,186 - $220,759
13,981 New
13,981 $220,000
Q2 2023

Aug 11, 2023
SELL
$4.89 - $10.57 $242,949 - $525,149
-49,683 Reduced 59.47%
33,853 $336,000
Q1 2023

May 16, 2023
BUY
$5.62 - $11.51 $469,472 - $961,499
83,536 New
83,536 $484,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email